Novel leukotriene A₄ hydrolase inhibitors

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.1, 1999-01, pp. : 91-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Leukotriene A4 (LTA4 ) Hydrolase as Potential Anti Inflammatory Agents

Current Pharmaceutical Design, Vol. 7, Iss. 3, 2001-02 ,pp. : 163-179

Bentham Science Publishers

Access to resources Recommend Favorite

Overview of recent drug discovery approaches for new generation leukotriene A₄ hydrolase inhibitors

By Çalışkan Burcu Banoglu Erden

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 49-63

Informa Healthcare

Access to resources Recommend Favorite

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Depsides as non-redox inhibitors of leukotriene B 4 biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid

By Kumar KC S. Muller K.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 4, 2000-04 ,pp. : 405-411

Elsevier

Access to resources Recommend Favorite

Effects of SA6541, a leukotriene A 4 hydrolase inhibitor, and indomethacin on carrageenan-induced murine dermatitis

By Tsuji F. Miyake Y. Enomoto H. Horiuchi M. Mita S.

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite